Genetic Re-programming of Stem Cells to Fight Cancer
There are few options for patients whose cancers have metastasized due to resistance to current therapies. Engineering of patient's own blood-forming stem cells to produce a continual supply of the immune system cell to attack cancer.
Primary: Safety and feasibility. Secondary: Persistence of gene-marked anti-cancer immune cells